- US-listed companies
- Verona Pharma plc
- Cash flow
Verona Pharma plc【VRNA】Cash flow
Market cap
$72.8B
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 |
| Stock-based compensation | 22 | 25 | 14 | 19 | 41 |
| Cash from operations | -45 | -33 | -60 | -50 | -122 |
| Capital expenditures | -0 | -0 | -0 | - | -1 |
| Cash from investing | 10 | -0 | -0 | - | -1 |
| Proceeds from issuance of term debt, net | 5 | - | 10 | 10 | 123 |
| Repayments of term debt | - | - | 5 | - | 52 |
| Cash from financing | 192 | -6 | 141 | 93 | 251 |
| Free cash flow | - | ||||
| FCF margin (%) | - | - |